The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization

Table 5

Competing risk analysis for the survival of patients before propensity score matching.

Characteristics	Competing risk analysis for survival
	Univariable analysis		Multivariable analysis
	HR (95% CI)	value	HR (95% CI)	value
Age (years)	0.993 (0.980, 1.006)	0.266
AST	1.004 (0.999, 1.009)	0.108
ALT	1.000 (0.993, 1.008)	0.931
Bilirubin	1.021 (1.004, 1.038)	0.014	1.027 (1.010, 1.043)	0.002
Albumin	0.990 (0.963, 1.016)	0.454
NLR	1.046 (0.996, 1.098)	0.072
PLR	1.000 (0.998, 1.003)	0.643
Maximal tumor size (cm)	1.064 (1.024, 1.106)	0.001	1.072 (1.027, 1.119)	0.001
Gender
Male	Ref	0.866
Female	1.034 (0.700, 1.528)
Smoking
Yes	Ref	0.176
No	1.210 (0.917, 1.595)
HBV infection
Yes	Ref	0.590
No	0.916 (0.667, 1.259)
HCV infection
Yes	Ref	0.602
No	0.899 (0.625, 1.199)
Cirrhosis
Yes	Ref	0.116
No	0.784 (0.579, 1.062)
Ascites
Yes	Ref	0.630
No	0.880 (0.523, 1.479)
TACE session
Once	Ref	0.016	Ref	0.059
Multiple times	0.496 (0.280, 0.878)		0.542 (0.287, 1.025)
Tumor number
1	Ref
≥2	1.076 (0.793, 1.459)	0.638
BCLC stage
A	Ref
B	1.113 (0.649, 1.909)	0.697
C	1.575 (0.884, 2.802)	0.122
AFP level
<200	Ref	0.879
≥200	1.025 (0.743, 1.415)
Child-Pugh
A	Ref	0.980
B	1.004 (0.699, 1.442)
ECOG score
0	Ref	0.027	Ref	0.143
1	1.424 (1.041, 1.948)		1.289 (0.917, 1.813)
Alcohol
Abstinence	Ref	0.004	Ref	0.046
Consumption	1.529 (1.143, 2.046)		1.377 (1.005, 1.886)